CLINICAL_TRIALS trial_result · 2021-12-09

Clinical Trial Update: Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia [Phase 3]

Phase 3 trial evaluating TV-46000 as maintenance treatment in adults and adolescents with schizophrenia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2021-12-09